Methods for treating abnormal growths in the body using a flow reducing implant
AssigneeNeovasc Medical Ltd.
InventorsShmuel Ben Muvhar, Ilan Shalev, Jonathan Tsehori, Nissim Darvish
Life of this patent
Estimating the term…
Abstract
Methods of using flow reducing implants for treatment of abnormal growths in the body are described. In embodiments of the claimed subject matter, a source blood vessel feeding the abnormal growth is first determined, and a flow reducing implant is then inserted into the source blood vessel to reduce the blood flow through the source blood vessel. The flow reducing implant includes at least one flared section for contacting a blood vessel wall, and at least one narrowed section defining a flow passage. Anchor tabs that lie generally in a plane of the flared section may also be employed.
Claims11
A method of treating abnormal growth in the body, comprising:
- determining a source blood vessel for the abnormal growth;
- inserting a flow reducing implant into the source blood vessel, said flow reducing implant including a flared section for contacting a blood vessel wall and a narrowed section defining a flow passage;
- and
- reducing blood flow through the source blood vessel with the flow reducing implant and without completely occluding the source blood vessel, thereby allowing blood flow through the source blood vessel after permanent implantation of the flow reducing implant, and
- wherein the reduced blood flow causes ischemia and necrosis of the abnormal growth.
A method of using a flow reducing implant for treatment of an abnormal growth in the body comprising:
- determining a source blood vessel for the abnormal growth;
- inserting the flow reducing implant into the source blood vessel, said flow reducing implant including a flared section for contacting a blood vessel wall and a narrowed section defining a flow passage;
- and
- reducing blood flow through the source blood vessel with the flow reducing implant and without completely occluding the source blood vessel, thereby allowing blood flow through the source blood vessel after permanent implantation of the flow reducing implant, and
- wherein the reduced blood flow causes ischemia and necrosis of the abnormal growth.
Dependencies are inferred from the claim text.